CDK7 inhibition for drug-resistant cancers

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer; sarcoma; solid tumors

Inhibiting CDK7 could treat hedgehog signaling-driven cancers resistant to SMO inhibitors. A

Read the full 195 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE